ORPHA:1652
Dent disease
Also known as: Dent syndrome · Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis · Renal Fanconi syndrome with nephrocalcinosis and renal stones · X-linked recessive hypercalciuric hypophosphatemic rickets · X-linked recessive nephrolithiasis
Publications
873
91.1th percentile
Trials
2
Interventional, condition-specific
Researchers
1,116
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare X-linked renal tubular diseases characterized by a primary proximal tubule dysfunction with low-molecular-weight proteinuria. Other renal features often include hypercalciuria, nephrolithiasis/nephrocalcinosis, and renal failure, among others. There are two subtypes: Dent disease type 1 characterized by an isolated renal in association with CLCN5 variants, and Dent disease type 2, often characterized by the addition of extra renal manifestations in association with OCRL1 variants.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015612
- MeSH:D057973
- UMLS:C0878681
- NCIT:C123260
Additional Mondo synonyms (3)
X-linked recessive hypophosphatemic rickets · low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis · renal Fanconi syndrome with nephrocalcinosis and renal stones
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
873 matched papers (575 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
2 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
873
873 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
873 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
575 in the last 10 years · medium confidence · 91.1th percentile (publications denominator)
Phrase hits: 873 · MeSH hits: 0
Who's working on it?
1,116
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Anglani F11 papers · 2026
Kidney Histomorphology and Molecular Biology Laboratory, Nephrology, Dialysis and Transplantation Unit, Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.
Papers in Europe PMC - 02Nozu K10 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 03Sakakibara N8 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 04Del Prete D7 papers · 2026
Kidney Histomorphology and Molecular Biology Laboratory, Nephrology, Dialysis and Transplantation Unit, Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.
Papers in Europe PMC - 05Horinouchi T7 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 06Lieske JC7 papers · 2026
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Papers in Europe PMC - 07Nagano C7 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. china@med.kobe-u.ac.jp.
Papers in Europe PMC - 08Yamamura T7 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC - 09Ceol M6 papers · 2026
Kidney Histomorphology and Molecular Biology Laboratory, Nephrology, Dialysis and Transplantation Unit, Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.
Papers in Europe PMC - 10Ishimori S6 papers · 2026
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 27 July 2026
2 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 82.4th percentile).
medium confidence · 82.4th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT00588562·RECRUITING·Rare Kidney Stone Consortium Patient Registry
Conditions: Primary Hyperoxaluria · Dent Disease · Cystinuria · APRT Deficiency·Matched via name phrase
- NCT02026388·RECRUITING·Rare Kidney Stone Consortium Biobank
Conditions: Primary Hyperoxaluria · Dent Disease · APRT Deficiency · Cystinuria·Matched via name phrase
- NCT06065852·RECRUITING·National Registry of Rare Kidney Diseases
Conditions: Adenine Phosphoribosyltransferase Deficiency · AH Amyloidosis · AHL Amyloidosis · AL Amyloidosis·Matched via name phrase
- NCT06017193·RECRUITING·Ultrasound for Socket Healing Evaluation
Conditions: Healing Wound · Alveolar; Wound · Alveolar Bone Loss · Image·Matched via name phrase
- NCT02780297·RECRUITING·Prospective Research Rare Kidney Stones (ProRKS)
Conditions: Hyperoxaluria · Cystinuria · Dent Disease · Lowe Syndrome·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Dent disease" OR "Dent syndrome" OR "Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis" OR "Renal Fanconi syndrome with nephrocalcinosis and renal stones" OR "X-linked recessive hypercalciuric hypophosphatemic rickets" OR "X-linked recessive nephrolithiasis" OR "X-linked recessive hypophosphatemic rickets"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Dent disease" OR "Dent syndrome" OR "Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis" OR "Renal Fanconi syndrome with nephrocalcinosis and renal stones" OR "X-linked recessive hypercalciuric hypophosphatemic rickets" OR "X-linked recessive nephrolithiasis" OR "X-linked recessive hypophosphatemic rickets"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 8 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T17:51:56.445Z
